ESMO 24: Keytruda Shows Strong OS Benefit In Two Women's Cancers

 
• By Kevin Grogan
  
Lorusso
Domenica Lorusso, (L) spoke to journalists about the KEYNOTE-A18 trial • Source: ESMO
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip